| Serial Number | 90785551 |
| Word Mark | 8 |
| Filing Date | Monday, June 21, 2021 |
| Status | 819 - SU - REGISTRATION REVIEW COMPLETE |
| Status Date | Tuesday, March 25, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 2, 2021 |
| Description of Mark | The mark consists of the number "8" with the Greek letters for Gamma and Delta within the center of the top circle with sixteen shaded circles varying in size to the right of the Greek letters and three horizontal lines within the center of the bottom circle. |
| Goods and Services | pharmaceutical preparations, namely, oncological preparations; reagent, diagnostic and therapeutic preparations for medical use in oncology; targeted medical preparations for use in oncology; pharmaceutical preparations for use in the treatment of cancer and tumors; pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; pharmaceutical and biological preparations for use in immunotherapies to improve immune system function; pharmaceutical and biological preparations combining immunotherapies and chemotherapies for treatments in the field of oncology; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of immunological and oncological diseases and disorders; pharmaceutical and biological preparations comprised of modified t cells used for multiple modes of treatment against tumor resistance and immunosuppression |
| Pseudo Mark | EIGHT |
| Goods and Services | development of diagnostic medical measuring and testing methods in the field of cancer therapy and treatment |
| Goods and Services | research, development, and evaluation of new products; pharmaceutical, medicine, and vaccine research and development services; technical research in the field of pharmaceutical studies; laboratory analysis and research into new drugs and pharmaceutical products; development of scientific measuring and testing methods in the field of oncology; design, development, research, and conducting clinical trials for others in connection with drugs, pharmaceuticals, and cellular therapies for the treatment and/or prevention of cancer; research and development services in the fields of oncology, immunotherapy, chemotherapy and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice and consultancy in the field of oncology |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, September 5, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, August 6, 2020 |
| First Use In Commerce Date | Thursday, August 6, 2020 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, September 5, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, August 6, 2020 |
| First Use In Commerce Date | Thursday, August 6, 2020 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, September 5, 2021 |
| Primary Code | 045 |
| First Use Anywhere Date | Thursday, August 6, 2020 |
| First Use In Commerce Date | Thursday, August 6, 2020 |
| Party Name | IN8bio, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10118 |
| Party Name | IN8bio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10118 |
| Event Date | Event Description |
| Thursday, June 24, 2021 | NEW APPLICATION ENTERED |
| Sunday, September 5, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 7, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, September 27, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, September 29, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 5, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, October 5, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, October 5, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, October 13, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 2, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 2, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 28, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, June 22, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, June 22, 2022 | SOU EXTENSION 1 FILED |
| Thursday, November 10, 2022 | SOU EXTENSION 2 FILED |
| Wednesday, June 22, 2022 | SOU EXTENSION 1 GRANTED |
| Friday, June 24, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 10, 2022 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 10, 2022 | SOU EXTENSION 2 GRANTED |
| Saturday, November 12, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, June 26, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, June 26, 2023 | SOU EXTENSION 3 FILED |
| Monday, June 26, 2023 | SOU EXTENSION 3 GRANTED |
| Wednesday, June 28, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, December 15, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, December 19, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, June 21, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, June 21, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, June 21, 2024 | SOU EXTENSION 5 GRANTED |
| Friday, December 15, 2023 | SOU EXTENSION 4 FILED |
| Friday, December 15, 2023 | SOU EXTENSION 4 GRANTED |
| Friday, June 21, 2024 | SOU EXTENSION 5 FILED |
| Monday, December 30, 2024 | USE AMENDMENT FILED |
| Monday, December 30, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Friday, March 7, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, March 7, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, March 25, 2025 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, March 25, 2025 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |